ANDA Sponsors: Update Your FDA Contacts List
Executive Summary
New policy allows more FDA staffers to answer certain questions about pending applications, rather than channeling them all through the regulatory project manager.
You may also be interested in...
GDUFA: Review Costs Continued To Climb Once Formal Review Goals Began
Generic drug reviews during the first year of formal review goals cost 70% more than during GDUFA's inaugural year.
GDUFA Stakeholder Deadline May Come After Negotiations Conclude
Generic drug user fee reauthorization talks remain on schedule and are expected to last about four months.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.